| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |